MEDICAL RESOURCES

Tepotinib MET kinase inhibitor

Status

• Tepotinib (also known as MSC2156119J) is an investigational small molecule inhibitor of the MET receptor tyrosine kinase

• Alterations in the MET signaling pathway are found in various cancer types and appear to correlate with aggressive tumor behavior and poor clinical prognosis

‡Tepotinib is the recommended international nonproprietary name(INN) for the MET kinase inhibitor (MSC2156119J).
Action SVG
Action SVG
Action SVG